Molecular characterization and immunopathological investigation of Avian reticuloendotheliosis virus in breeder flocks in Egypt.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X (Electronic) Linking ISSN: 1743422X NLM ISO Abbreviation: Virol J Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BioMed Central, 2004-
    • Subject Terms:
    • Abstract:
      Background: Reticuloendotheliosis virus (REV) is an oncogenic immunosuppressive retrovirus that infects different kinds of avian species; posing significant economic losses to the poultry industry worldwide.
      Methods: In Egypt, there is an unidentified disease associated with the runting-stunting syndrome with neoplasia, suspected to be REV, that has been continuously monitored in several breeder flocks. To diagnose and analyze REV by cell cultures, enzyme-linked immunosorbent assay (ELISA), histopathological investigation, the polymerase chain reaction (PCR) test, and sequencing analysis, 200 blood samples, and 50 tissue specimens were collected. The current study targets the occurrence and genetic characteristics of a viral neoplastic disease, resembling REV infection, circulating in breeder flocks from 2022 to 2023 in the Ismailia, El-Sharqia, and El-Dakahliya governorates.
      Result: Here, REV was isolated on chicken embryo fibroblast cell culture; exhibiting cell aggregation, rounding, and cell detachments. Collectively, only 70 serum samples were positive for anti-REV antibodies with seroprevalence rates of 35% based on the ELISA test. The histopathological observation demonstrated lymphoreticular tumors in the liver, spleen, and other examined organs. The immunohistochemical staining method confirmed the REV-positive signals in all examined organs (liver, kidney, spleen, bursa, ovaries) except for the heart. The PCR assay of the LTR gene assessed 370 base pairs with only 5 positive samples with a percentage of 16.6%. Three positive samples were further sequenced and submitted to the Genbank under accession numbers (PP763709, PP763710, PP763711). Phylogenetic analysis of the REV-LTR gene showed that our three isolates (Sharquia-1-REV, Ismilia-2-REV, Mansoura-3-REV) are REV subtype III which predominantly circulated in breeders in Egypt. These three isolates are highest similar to American, Chinese, and Taiwanese REV reference strains, and other Egyptian strains with nucleotide identity percentages of 100%, 99%, and 99%; respectively, and on the amino acid identity level were with (99-100%), (98%, 99%), (99%, 100%); respectively.
      Conclusions: This study established that REV infection was extensively distributed in the breeders and became one of the causes of the clinical outbreaks of tumors, raising awareness of REV as the causative agent of avian oncogenic disease in Egypt.
      (© 2024. The Author(s).)
    • References:
      Poult Sci. 2021 Jan;100(1):19-25. (PMID: 33357681)
      Vet Microbiol. 2019 Oct;237:108418. (PMID: 31585637)
      Poult Sci. 2021 Aug;100(8):101099. (PMID: 34174570)
      J Vet Sci. 2004 Mar;5(1):49-58. (PMID: 15028885)
      Vet Microbiol. 2013 Sep 27;166(1-2):68-75. (PMID: 23845736)
      J Vet Diagn Invest. 2019 Sep;31(5):761-765. (PMID: 31378167)
      Vet Med Sci. 2019 Nov;5(4):508-511. (PMID: 31347279)
      Vet Ital. 2011 Apr-Jun;47(2):147-53. (PMID: 21706467)
      Vet World. 2024 Jun;17(6):1271-1280. (PMID: 39077436)
      Poult Sci. 2024 Jun;103(6):103722. (PMID: 38626691)
      Virol J. 2024 Apr 10;21(1):83. (PMID: 38600532)
      Virus Genes. 2015 Jun;50(3):418-24. (PMID: 25850423)
      Biology (Basel). 2020 Aug 31;9(9):. (PMID: 32878059)
      Avian Pathol. 2018 Aug;47(4):364-374. (PMID: 29533078)
      J Vet Med Sci. 2006 Dec;68(12):1315-20. (PMID: 17213700)
      Rev Sci Tech. 2000 Aug;19(2):544-64. (PMID: 10935279)
      Viruses. 2017 Jun 21;9(6):. (PMID: 28635675)
      Virology. 1979 Feb;93(1):20-30. (PMID: 219596)
      J Vet Res. 2018 Dec 10;62(3):257-260. (PMID: 30584601)
      Avian Pathol. 2008 Aug;37(4):451-6. (PMID: 18622864)
      Vet Sci. 2019 Nov 20;6(4):. (PMID: 31756886)
      Poult Sci. 2017 Sep 1;96(11):3893-3895. (PMID: 29050414)
      Poult Sci. 2019 Jun 1;98(6):2432-2438. (PMID: 30668827)
      Viruses. 2022 Apr 13;14(4):. (PMID: 35458529)
      BMC Vet Res. 2019 Aug 13;15(1):288. (PMID: 31409367)
      Arch Virol. 1987;93(3-4):233-45. (PMID: 3030238)
      J Vet Diagn Invest. 2020 May;32(3):389-393. (PMID: 32233842)
      Mol Biol Evol. 2016 Jul;33(7):1870-4. (PMID: 27004904)
      Vet Sci. 2022 Dec 26;10(1):. (PMID: 36669017)
      Virus Genes. 2017 Jun;53(3):386-391. (PMID: 28194622)
      Arch Virol. 2014 Aug;159(8):2051-7. (PMID: 24643331)
      Nucleic Acids Res. 1997 Dec 15;25(24):4876-82. (PMID: 9396791)
      Microb Pathog. 2012 Aug;53(2):57-63. (PMID: 22579709)
      J Virol. 1994 Jan;68(1):308-19. (PMID: 8254742)
      J Appl Microbiol. 2015 Apr;118(4):803-8. (PMID: 25641090)
      Virol J. 2013 Mar 22;10:92. (PMID: 23521848)
    • Contributed Indexing:
      Keywords: Reticuloendotheliosis virus (REV); Histopathology; Immunohistochemistry; PCR; Sequencing
    • Accession Number:
      0 (Antibodies, Viral)
    • Publication Date:
      Date Created: 20241023 Date Completed: 20241023 Latest Revision: 20241030
    • Publication Date:
      20241031
    • Accession Number:
      PMC11515750
    • Accession Number:
      10.1186/s12985-024-02525-5
    • Accession Number:
      39438969